AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy
The purpose of the study is to determine whether Fludarabine in combination with cytarabine is more effective than high-dose cytarabine in post-remission therapy for patients with AML1-ETO acute myeloid leukemia.
Acute Myeloid Leukemia|AML1-ETO Fusion Protein Expression
DRUG: Fludarabine|DRUG: Cytarabine
Percentage of participants with disease recurrence, one year
Percentage of Participants in survival, one year
The purpose of the study is to determine whether Fludarabine in combination with cytarabine is more effective than high-dose cytarabine in post-remission therapy for patients with AML1-ETO acute myeloid leukemia.